BCF Technology has launched a competition in which the person who submits the best photograph with the theme of: All in a day's work - animal imaging, will win an iPad 2.
To enter the competition, you need to post your photographs, (and tell BCF a little about the story behind the images) at www.facebook.com/bcftechnology or email them to: info@bcftechnology.com
Jason Rogers, Marketing Manager at BCF said: "We wanted to create a fun way to show just how interesting and different each days work is when imaging animals. We have made the competition open to all that work with animal imaging including our staff, dealers and vets, vet nurses, animal contractors, etc from all over the world.
"It is great to see the BCF office in the States and our international dealers also promoting the competition in their own countries, making the competition truly international. Response to the competition has been fantastic - see our facebook page to some entries for yourself."
The closing date for the competition is 30th September 2011.
For more information, visit: www.bcftechnology.com
The Land Rover Burghley Horse Trials has announced a £15,000 bursary to the Animal Health Trust. The bursary will be used to help fund the development of a rapid result blood test to identify horses infected with Strangles.
The AHT has already developed a test that can detect the disease, however the result is not known for 48 hours. The aim of the new research is to develop the test to produce a result within 10 minutes. The test, which is being developed in conjunction with Forsite Diagnostics Ltd, will be a useful tool for disease screening at sales and competitions.
"As an independent charity we receive no government funding and this bursary is extremely important to us and we are delighted to be working in partnership with The Land Rover Burghley Horse Trials on this specific project," said Dr Richard Newton of the AHT who is carrying out the research in partnership with Professor Andrew Waller. "Without this vital funding to carry out the painstaking work that will give us the confidence to launch the test, it will remain no more than a theoretical possibility."
The Bursary will be presented at this year's Land Rover Burghley Horse Trials (1- 4 September 2011) - in recognition of the 50th Anniversary of the event.
"With increasing horse movement, not only world-wide but closer to home between competitions and livery yards, preventing the spread of disease is an increasingly important challenge facing the horse world," said Elizabeth Inman Director of the Trials. "We are delighted to be able to play a part in this challenge and hope that this anniversary bursary will help to fast-track this new test out of the laboratory and into the field and thereby help reduce the spread of what is a horrible disease for horses and owners."
Boehringer Ingelheim Vetmedica has launched new, more palatable Metacam Chewable Tablets.
According to the company, the tablets are proven to be taken by 90% of dogs voluntarily1 and 80% will even take them from the floor1 which aids compliance. Available in pop-through blister strips of seven for easy dispensing and administration, the 1mg and 2.5mg Metacam Chewable Tablets are packed in boxes of 84 and priced the same per tablet as the current tablet range.
Claire Fowler, companion animal marketing manager at Boehringer Ingelheim, said: "The existing Metacam Chewable Tablets are readily accepted by most dogs. However, to appeal to as many dogs as possible, we have launched an even more appetising 'beefed up' meaty flavour."
For further information on the new flavoured Metacam tablets, including special offers, please contact your Boehringer Ingelheim territory manager or call 01344 746959.
The BSAVA has announced the launch of its third smartphone app - the BSAVA Small Animal Formulary App.
This member-only access app is available to download now from iTunes and Android Market and offers the same reference materials found in the latest 7th edition printed version.
The BSAVA says the app contains more than 450 drug monographs and a wealth of additional information, allowing easy and rapid access to vital information about those medications that veterinary surgeons most commonly prescribe. It is hoped that the convenience of having the BSAVA Small Animal Formulary on a smartphone will mean that vets in practice will always have this valuable reference tool within easy reach.
Once the app is installed it will ask for a validation code that can be obtained from the smartphone app validation code page within My BSAVA pages at www.bsava.com. All future BSAVA member-only smartphone apps will be validated using the same process.
BSAVA IT Manager Emma Hayes said: "BSAVA is continually aiming to provide a range of valuable member benefits in a variety of formats so they can be used in the most efficient and effective way by our members. The BSAVA Formulary was a natural candidate for release as a mobile application, following the successful launch as an online searchable database at Congress in April. By developing this application it has also provided us with a platform that will enable us to produce additional useful applications in the future that can provide unrestricted content for our members."
The BSAVA Small Animal Formulary App follows on from the BSAVA Congress App and the BSAVA Guide to the use of Veterinary Medicines App. You can find out more about these other BSAVA smartphone apps through My BSAVA at www.bsava.com.
Ceva Animal Health has added a new session to its Cardio Academy CPD website entitled 'Thoracic X-rays: Normal Features'.
In this 30 minute multimedia presentation, the cardiology specialist Nicole Van Israël discusses how the normal thoracic radiograph should appear, as well as the differences observed between breeds. Participants can then receive a CPD certificate by completing the quiz for this session. The Cardio Academy CPD website is free of charge and can be accessed by visiting http://www.cardioacademy.cevalearn.com/.
The first three sessions in the series can still be viewed on the website. They cover the 'Pathophysiology of Mitral Valve Disease, by Adrian Boswood, 'Clinical Examination of the Cardiac Dog', by Gérard Le Bobinnec and 'Thoracic X-rays: How to Proceed' by Nicole Van Israël.
Dechra Veterinary Products has added a new webinar: 'Otitis Externa - Recent advances in the treatment of ears' to The Dechra Academy, the online training suite from Dechra Veterinary Products.
Presented by Sue Paterson, MA VetMB DVD DipECVD MRCVS RCVS & European Specialist in Veterinary Dermatology, the webinar accounts for 1.5 hours CPD and covers such topics as ear anatomy, cytology and the creation of treatment plans.
Carol Morgan, Dechra Brand Manager said: "We are dedicated to providing educational resources to support the veterinary profession. The otitis webinar is the latest addition to our range of high quality key-opinion-leader-led CPD on The Dechra Academy."
The webinar is now available to view on demand at www.dechra.co.uk/academy.
Virbac Animal Health has developed a 'Yield Wheel' to show vets the additional income that farmers can achieve through taking a tailored and more flexible approach to the management of their dairy herd through the dry period.
The company says this approach is made easier using its Cephaguard DC dry cow therapy.
While a 60 day drying off period is required for some cows, others may not need to be withdrawn from milk production for the full period, including those with a high body condition score in late lactation, high yielders and older healthy cows with an increased tendency for weight gain. For cows in these categories, a shorter drying off period can mean additional days of milk production and extra income for the farmer with no negative impact on future lactations or the cow's overall health.
The Yield Wheel shows how production and income can be maximised on a sliding scale from a standard 60 day drying off period down to 36 days, the shortest drying off period. It also shows the benefits which can be gained in terms of reduced discarded milk days in the case of cows with an unclear calving date.
Cephaguard DC dry cow therapy is the most recent entrant to the dry cow therapy market. With its 35+1 day withdrawal period in milk, Virbac says it offers farmers increased flexibility for the management of dry periods.
Brigitte Goasduf, Ruminants Product Manager at Virbac said: "For dairy farmers, it's all about milk. They're looking to optimise production and reduce waste while also ensuring that they treat infections effectively at drying off and prevent new infections which may reduce yield during the next lactation.
We've produced the Yield Wheel to highlight the tangible benefits of taking a customised and more flexible approach to drying off using Cephaguard DC. The data is provided in a practical and straightforward way and demonstrates the potential yield benefits that can be achieved from an overall herd management and income perspective. We hope it will prove a useful tool."
Pfizer has released the results of its first Performance Index (formerly the Fort Dodge Index) which shows mildly improved trading conditions for the companion animal veterinary market in the first quarter of 2011.
Those aspects of veterinary business that showed an improvement in the first quarter of 2011 include: turnover growth (+0.8%, up from -0.1% in March 2010); client retention (+0.1%); the average number of visits per year (+ 0.17%); annual transaction value (+ 1.1%); average transaction value (+0.8% to £41.74); fee per product service (+0.2%) and products and services sold per visit (+0.6%).
Leveraged sales (typically pet-care products), which were down 2% (from 40% to 38%) in 2010, have increased 0.9% in the first quarter of 2011 to make up 39% of practice transactions.
Less positively and pointing to the need for veterinary practices to implement ongoing marketing initiatives, the number of new clients coming into practice is down (-0.4%) as is the number of active clients (-0.26%). Revenue from loyal clients (those that visit the practice for additional products and services, particularly vaccination and other preventative healthcare programmes) was static. Although flat growth is an improvement on previous reports, this is still a concern, as it is these clients who are the driver for revenue growth in many practices.
Pfizer Business Consultant, Simon Fowler said: "Although the figures are only very slightly improved this does mirror what we are seeing in practices that we visit. Practice turnover growth of 0.8%, while only small, is much better than any quarter in 2010. So we may be seeing the first green shoots of recovery, but there's still no room for complacency. Before we all breathe a collective sigh of relief, however, it should be remembered that as this is the first report for 2011 it is only an early picture, while a fuller story will be gleaned from the second report, which will show results from the first six months of the year.
"What is clear is the need for practices to market themselves in order to attract new clients, increase growth from active clients and increase client loyalty. VetSupport+ includes a range of marketing services to help practices in this respect. A practice has already achieved TV coverage via our Public Relations support service, while others are using PressRoom newsletter templates to keep potential and existing clients up to speed with the practice's news."
Further information about Pfizer's VetSupport+ service is available at www.vetsupportplus.co.uk.
RCVS President Peter Jinman has announced that a review will be carried out into the circumstances that led to higher-than-expected expenditure on the College's new database and development works in the Lower Ground Floor at Belgravia House.
He said: "That the work was required was not in question, but that expenditure over the extended timescale of both projects rose above initial budgets is both to be regretted and subject to analysis as to cause."
The RCVS Officer team has asked Professor Bill McKelvey - a new member of the College's Governance Review Group - and two of the College's Privy Council-appointed Council members to look at all aspects that relate to its budgeting and expenditure process.
The setting up of the enquiry has been cleared and approved by Sir David Barnes, who chairs the RCVS Governance Review Group.
All reports from Professor McKelvey will be scrutinised by the Governance Review Group, Officers, the Planning and Resources Committee and Council.
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
References
Pfizer has repeated it's call for veterinary practice staff to take part in its Vet Support+ independent, industry-wide survey of employee engagement.
The survey gives practice team members, who are not partners or owners, the chance to have their say about their role and career and the future of the profession. Participants are asked to consider how they feel towards their practice and delve into issues on teamwork and communication, management techniques, personal development opportunities and working environment.
More than 3,000 vet practice staff have already completed the survey, a phenomenal early response which suggests practice employees are keen to have their voices heard. However, the closing date for the survey isn't till Friday 29th July, so if you haven't yet had a chance to do the survey, there is still time.
Pfizer Business Consultant, Vanessa Wilson, has more than 20 years experience helping businesses, teams and individuals achieve their goals. She is not surprised at the significant early response: "Questions on the level of employee engagement and satisfaction come up all the time in the work we do with practices. I'm not surprised that staff are using this opportunity to have their voice heard.
"Once completed, this survey will provide some very useful data and direction for the industry as a whole and I'd like to think it will identify opportunities for both individual career development and practice growth."
All members of staff employed within a practice who have not received a mailing and wish to participate are welcome to respond online. http://www.noesis-mi.com/surveys/employeesurvey/.
Pfizer says the findings, which are expected to be released in the autumn, will deliver a national and regional view of the current employee engagement landscape.
For further information about Vet Support+ Business Services from Pfizer visit www.vetsupportplus.co.uk.
The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).
In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.
However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.
The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.
The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.
Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.
"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.
"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.
"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."
Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.
"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."
Fabtek Solutions has announced the launch of Meditek, an activated carbon wound dressing which has been impregnated with silver to enhance its antibacterial qualities.
Joy Coutts from Fabtek Solutions said: "Meditek uses Zorflex which is a 100% pure activated carbon fibre. It has a huge surface area due to its microporous structure, and a permanent electrostatic charge that attracts bacteria towards it, where they are immobilised and retained. When removed from the substrate, the bacteria die, but the microscopic particulates of metallic silver accelerate the bacteria kill.
"Better still, Meditek carries no risk phases as it's non toxic and non invasive."
Joy added: "We are commercial members of the Vet Wound Library, an initiative designed to help promote modern wound care to veterinary professionals, it also means members can try our dressings for free."
According to Fabtek, Meditek has been tried and tested by vets and produced excellent results. The company's website also features some case studies which show the wound before and after the use of Meditek.
Dressings are available in 10cm x 10cm, and 15cm x 25cm sizes, which can be cut to fit. Prices start from £35 for a box of five.
For more information, see http://www.fabteksolutions.com/, email admin@fabteksolutions.com or call 07794094011.
The RCVS Charitable Trust has teamed up with the Foundation for Social Improvement (FSI) for the launch of the Great Big Small Charity Car Draw 2011.
The draw enables small charities, such as the RCVS Charitable Trust, to sell tickets to supporters which offer a chance of winning a brand new Fiat 500 1.2 Pop. Each ticket costs only £2, and the Trust will receive £1.90 for every ticket it sells.
Tickets can be bought securely online at http://trust.rcvs.org.uk/support-us/get-involved/win-a-fiat-500/ or directly from the Trust office on 020 7202 0721 or by emailing fundraising@rcvstrust.org.uk. Books of tickets are also available to sell to colleagues, friends and family. The deadline for buying tickets is September 16th 2011 with the draw taking place on 25th October 2011.
Here are a few examples of what reviewers have been saying about the Fiat 500:
"The Fiat 500 is both stylish and fun. The modest running costs complement the engaging handling. So, this nimble little city car can be enthusiastically thrown into corners and it should emerge grinning like a Cheshire Cat." Motoring.co.uk
"I love my Fiat 500 1.2 Pop from the moment I drove off in it. Great fun to drive on the motorway and in town for parking into slots others cannot!" What Car?
"It's absolutely fantastic. It drives like a dream. Everybody admires it." Fiat Forum
For further information on the car draw, please contact Fiona O'Regan on 020 7202 0743 or Rebecca Fellows on 020 7202 0721. Alternatively email fundraising@rcvstrust.org.uk.
Novartis Animal Health has announced that Crovect 1.25% Pour-On solution for sheep, a broad spectrum ectoparasiticide, is now licenced for the treatment of ticks, with a persistent efficacy of ten weeks and the majority killed within three hours.
Crovect also works in the treatment and control of headflies, the treatment of biting lice, and the prevention and treatment of blowfly strike in sheep.
Crovect has a meat withhold period of eight days. Novartis says this makes Crovect the long-lasting tick treatment with the shortest meat withhold period available, which is of use to farmers taking lambs to market at this time of year.
Helen Langham, Brand Manager at Novartis Animal Health said: "Farmers now have another option available for effective and long lasting tick treatment for their flocks, and one that can be flexibly used in lambs to be marketed. This should greatly reduce the worry of tick infestation along with the associated welfare and economic problems, and we are pleased to bring this solution to the market".
Unite, the largest trade union in the country, has announced that up to 17,000 members of the UK veterinary profession could become members within the next five years, following the establishment of the British Veterinary Union (BVU)The union says it will be able to give veterinary surgeons, veterinary nurses, practice managers, support staff and students in all disciplines, the additional muscle to tackle employment problems in the workplace, such as pay, contracts, bullying and professional development.Unite's General Secretary, Len McCluskey said: 'As a progressive trade union, Unite warmly welcomes BVU into the Unite family. The fact that a highly-regarded profession is looking to Unite for support in employment matters is an indication of the validity and relevance of trade unions in 2011 Britain.' Dr Shams Mir, Chairman, Professional Advisory Committee, British Veterinary Union in Unite said: 'Our biggest challenge will be to change the mindset of our profession to address the deep-trenched problems of working conditions and terms of employment for vets and nurses, and safeguarding their professional status. But, most importantly, we have to overcome the sense of fear amongst veterinary professionals in raising legitimate employment issues.''Veterinary professionals face the same problems in their working lives as any other health professionals, but never before have vets had a trade union to support and represent them. BVU in Unite is a great opportunity for the profession to develop and expand, and is a goal that many have aspired to for years. We believe that up to 17,000 veterinary professionals could join BVU in Unite in the next five years.'Dr Mir said that research has revealed that vets suffer from much higher levels of anxiety and depressive symptoms and they are five times more likely to have suicidal thoughts and four times more likely to commit suicide compared to the general UK population.
He said: 'Sadly, according to the most recent Royal College of Veterinary Surgeons' survey of the profession, nearly half of the responding vets and nurses said that if they had their time again, they would choose a different profession.' 'This is a wake-up call for our profession and we must act to address all the underlying problems leading to this situation.'
Further information is available at: www.bvu.org.uk and www.unitetheunion.org/bvu
Virbac has announced that it will repeat its EasOtic promotion through which practitioners that make multiple purchases of the award-winning otitis treatment can claim an ear model and specialist ear instrument kit.
The models, which show the anatomy of a healthy canal on one side and the changes associated with chronic damage on the other, are approximately 15cm high and can be used as a visual aid to show clients the consequences of untreated chronic ear disease.
The specialist ear instrument kits, worth £100, have been designed in consultation with veterinary dermatologists. They consist of a haemostat, ear forceps, three various cerumen scoops and a Spreulls ear-flushing needle.
Product Manager Chris Geddes MRCVS said: "Basically it's the best ear equipment for daily use by practitioners. Last year we were overwhelmed by the demand of both promotions, so we've decided to repeat the offer again this year."
The models and kits are available with multiple purchases of EasOtic and the neutral pH glycotechnology ear cleaner Epi-Otic.
For details of how you can obtain a model and/or kit for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
The British Veterinary Association and its specialist cattle division the British Cattle Veterinary Association have welcomed today's announcement by Defra that it is strongly minded to include a controlled cull of badgers as a key component of the bovine tuberculosis (TB) eradication plans for England.
The two associations have long supported the need to control TB in both cattle and wildlife, including the need for a targeted, humane cull of badgers in specific parts of the country.
Following a consultation exercise which closed in December 2010, Defra has today announced:
The BVA and BCVA jointly responded to Defra's 2010 consultation to say that the available science supported the case for a badger cull, alongside the need for stricter cattle control measures, in those areas where badgers are regarded as a significant contributor to the persistent presence of TB. The response also emphasised strongly that any cull of badgers had to be done in a humane and effective manner.
The BVA and BCVA say that today's announcement shows Defra has listened closely to their concerns. Through the consultation response the BVA and BCVA raised the issue of the efficacy of an industry-led cull using controlled shooting (as opposed to cage trapping and shooting) and stated firmly that any cull must be monitored for humaneness. Both of these issues have been considered in depth by Defra and appear to have been addressed in the plans.
The associations say they will be looking closely at the detail of the guidance issued today and will be responding to the consultation.
Harvey Locke, President of the BVA, said: "The BVA and BCVA have long argued for a targeted, humane badger cull to be used alongside stricter cattle controls. We believe that failure to tackle wildlife sources of TB infection has prolonged the presence and enhanced the spread of infection in all affected species populations.
"We recognise that this is a very emotive and difficult decision but we believe that the science supports this policy and we support Defra's commitment to tackling this devastating disease.
"We are particularly pleased that this announcement has not been delayed until after the summer recess, which demonstrates the seriousness of the need to tackle TB."
John Fishwick, President of BCVA, added: "We welcome today's announcement which indicates that a humane and carefully targeted cull of badgers can contribute to the control of this dreadful disease.
"We are particularly pleased that the veterinary profession's concerns that any cull must be humane and well monitored appear to have been listened to and we will now study the proposals in detail.
"An industry-led cull will be an enormous undertaking for everyone involved and it is vital that we get the detail right from the outset; for the sake of cattle, wildlife and industry."
Meanwhile, the RSPCA has expressed its devastation at the announcement.
According to the charity, new research has been published which shows that badger culling can more than double the risk of TB infecting cattle1. High-profile voices such as Sir David Attenborough and government adviser Lord John Krebs have also weighed in, saying a cull could "make the situation worse" and be "ineffective".
David Bowles, Director of Communications for the RSPCA, said: "Today is a black day for badgers - a day we have been dreading.
"At a time when the Welsh government has stepped back from a cull, the government in England is slowly shredding its own animal welfare credentials."
The RSPCA says it agrees that action is needed to combat bovine TB in cattle, but does not think action is synonymous with culling. The charity believes that vaccination of badgers, increased levels of testing, improved biosecurity and stricter controls on the movement of cattle are more effective ways of dealing with the problem in the long-term and eradicating bovine TB in cattle for good.
Colin Booty, senior scientist for the RSPCA, said: "The RSPCA is sympathetic to farmers struggling to cope with the effects of this crippling disease and thinks that the problem of bovine TB in cattle needs a sustainable and effective solution.
"But this is not such a solution. We believe that the government have taken the wrong fork in the road with this risky policy.
"This cull will contribute little or nothing to the long-term goal of eradicating TB nationally. Instead it will wipe out huge numbers of this much-loved species, including many animals which are healthy."
1 The New Medical Research Council study came from Imperial College London and were published in the Royal Society Journal Biology Letters. They were based on analysis of data from the 10-year Randomised Badger Culling Trial set up by the Department for Environment, Food and Rural Affairs (Defra) in 1998.
The BSAVA has launched a series of client information sheets for drugs commonly used off-label.
The information sheets were the brainchild of Professor Ian Ramsey, Editor-in-Chief of the BSAVA Small Animal Formulary. He said: "As a referral vet I write a lot of letters to owners and vets that include instructions about the drugs that I am prescribing or dispensing for a patient. Often these drugs are unusual or cytotoxic, and are very commonly only authorized for human patients. As Editor of the Formulary I am acutely aware of the responsibility that I have for making sure owners understand what these drugs are for and what the side effects might be."
The BSAVA says it hopes the leaflets will overcome the challenge veterinary surgeons have in remembering all the drug information that needs to be related to clients, and the problem of clients forgetting what they have been told verbally by the clinician during a consultation.
In addition to a basic introduction to the Prescribing Cascade, each of the client leaflets provides the following information:
The first batch of client information leaflets, which relate to the following medications prescribed for dogs and cats, is now available for members to download from the BSAVA website (http://www.bsava.com/):
Each of the leaflets has a space for veterinary practices to add their details before distributing them to their clients, and the BSAVA says more may be added during 2011.
The World Small Animal Veterinary Association is inviting nominations for its 2012 awards.
The awards, which recognise the achievements of veterinary surgeons around the world in advancing the care of companion animals, are made annually and will be presented during the 2012 WSAVA World Congress in Birmingham from 12-15 April 2012.
Nominations for the 2011 awards have already closed and will be presented at this year's event, which takes place in Jeju, Korea from 14-17 October.
Nominations are invited for the following awards:
The WSAVA Hill's Pet Mobility Award This recognises the outstanding work of a clinical researcher in the field of canine and feline orthopaedic medicine and surgery. Through improvements in the mobility and quality of life of pets, the research should have contributed significantly to the well-being of pets' lives and to the human-animal bond worldwide.
The WSAVA Hill's Excellence in Veterinary Healthcare AwardThis recognises the outstanding work of a veterinary surgeon in promoting companion animal health care and the human-animal-veterinary bond through leading edge clinical nutrition and through advanced medical and surgical techniques which enrich relationships between people and their pets.
The WSAVA International Award for Scientific Achievement This recognises the outstanding contribution of a veterinary surgeon who has furthered the advancement of knowledge of the cause, detection and management of disorders in companion animals.
In addition to these awards, the WSAVA Executive Board makes a special additional award for Service to the Profession. The award recognises exemplary service by a vet to foster and enhance the exchange of scientific and professional ideas throughout the world. For 2012, the award will again be sponsored by Dr John and Mary Holt, Past WSAVA President and Service to the Profession Award recipient, both of whom remain well recognized supporters of the profession.
Finally, the WSAVA's Global One Health Award will also be presented to an individual judged to have made particular progress in an aspect of One Health relating to companion animals. A second award aimed at encouraging younger members of the profession to embrace One Health will also be made to the individual who gives an oral or poster presentation at the 2012 Congress which best encapsulates the One Health concept. The recipients of these awards are nominated by members of the WSAVA's Scientific Advisory and One Health Committees in conjunction with the Local Hosting Committee.
Professor Jolle Kirpensteijn, President of the WSAVA, said: "It's important to recognise and celebrate the outstanding work of our colleagues around the world as they continue to advance the care of companion animals. The developments and scientific breakthroughs they work so hard to achieve are helping to improve the daily quality of life and health experienced by many millions of animals around the world.
"A WSAVA Award confers recognition and gratitude from the global veterinary community. Each year, we receive a higher number of entries and we look forward to reviewing the nominations for the 2102 awards. We are, of course, grateful to Hill's Pet Nutrition for its generous sponsorship and for its continuing support of the WSAVA. The awards are just one of the ways in which we work to deliver our joint vision to foster the development of veterinary knowledge on a global scale."
Nominations must be received by the WSAVA Secretariat by 1 September 2011 and can be submitted by email (wsavasecretariat@gmail.com) or post. They should include a covering letter, nominee CV and list of nominee publications. Full contact details are at www.wsava.org/contact.htm.
BEVA is giving its members the opportunity to participate in a free practice benchmarking survey, to help them ensure their business is being run as efficiently and profitably as possible. The results of the research will be released at BEVA Congress, 7th-10th September 2011.
The Association has worked with Hazlewoods, chartered accountants and business advisors to the veterinary profession, to develop a detailed benchmarking questionnaire for equine veterinary practices, which allows businesses to compare their practice, anonymously, with other similar practices. The report should identify areas for profit improvement, including practice structure and pricing and may also highlight other potential methods of income generation.
Mark Beaney, partner at Hazlewoods and specialist advisor to the veterinary profession, said: "This is a super opportunity for equine practices to obtain helpful, free advice on how to fine-tune their business for maximum efficiency, delivery and profit. The questionnaire should take no more than half an hour to complete and in return we will provide you with a confidential individual report, with your practice data benchmarked."
Mark will present an overall report on the equine veterinary market at BEVA Congress on Saturday 10th September. All participating practices will remain anonymous. The benchmarking survey can be downloaded from the BEVA website at: http://www.beva.org.uk/news/view/59 and must be completed by 30th June 2011.
BEVA Congress runs from 7th-10th September 2011 at the Liverpool Arena Convention Centre, Liverpool. This year BEVA will be celebrating its 50th anniversary - for further information and to register visit http://www.beva.org.uk/.
Free places on Vétoquinol's webinar: 'Chronic Pain in the Geriatric Dog: Decision Making and Risk Management' are going fast, according to the company, and those wishing to attend are being advised to register as soon as possible.
Vétoquinol says that at one point, 200 vets registered in just 3 hours, demonstrating the extent to which vets are finding this to be a challenging topic when it comes to managing their day to day case load.
The webinar takes place at 8.30pm on Wednesday 15th June 2011 and the talk is being delivered by Dr. Jo Murrell, Senior Lecturer in Veterinary Anaesthesia at Bristol Vet School and holder of The European Diploma in Veterinary Anaesthesia and Analgesia. She said: "Decision making can be a complex business when so many factors have to be taken into account. We all see geriatric dogs with painful conditions reasonably frequently and concurrent diseases are common. I will be aiming to describe a way to balance out the risks and benefits, to take into account client's concerns and develop a more logical, rational approach to treatment."
To register for the free webinar go to www.thewebinarvet.com/vetoquinol. Enter the code veto11 to obtain the webinar free of charge.
The World Organisation for Animal Health (OIE) and the Food and Agriculture Organisation of the United Nations (FAO) have announced that today marks the declaration of the eradication of rinderpest, one of the world's most dreaded animal diseases.
The BVA likened this announcement in the history of animal health to that of the eradication of smallpox in humans.
The announcement came during the 79th General Session of the World Organisation for Animal Health (OIE), held in Paris. The global freedom status will be ratified by Ministers of Agriculture at the Food and Agriculture Organization of the United Nations (FAO) conference in June.
Rinderpest, also known as cattle plague, has ravaged cattle and the human populations that depend on them throughout history. It was rinderpest that led to the formation of the OIE in 1924 following a new incursion of the rinderpest virus in Europe, via the port of Antwerp.
Dr Peter Roeder, who was Secretary of the Global Rinderpest Eradication Programme from 2000 to 2007, said: "Once a dream, rinderpest eradication is now a reality. Not only does this magnificent achievement help to protect the livelihoods of many millions of livestock-dependent farmers but, because it removes a serious constraint to livestock trade, it has a major positive impact on many countries' economies. If we can truly learn the lessons from rinderpest eradication there is no reason why we couldn't see other diseases brought to global extinction with similar pro-poor and economic impact."
BVA President Harvey Locke added: "This monumental achievement testifies to the dedication of the veterinary services of affected countries and illustrates how vets and veterinary science can have a global impact. With that in mind I am absolutely delighted that Dr Roeder will be presenting the plenary Wooldridge Memorial Lecture at this year's BVA Annual Congress. Entitled 'Making a global Impact' Dr Roeder will discuss how vets can contribute to disease control on a global scale.
"I should also like to pay tribute to two British veterinary surgeons who made seminal contributions to the global effort to eradicate rinderpest. Gordon Scott, a rinderpest researcher, and Walter Plowright who developed the tissue culture rinderpest vaccine, were both leading lights of the rinderpest eradication effort. Sadly they are no longer with us to witness this milestone in veterinary history."
As part of the BVA's celebration of World Veterinary Year Vet2011 and to further illustrate how vets and veterinary science can have a global impact the Overseas Group is organising on Friday 23 September a full day's programme at BVA Congress: exploring current issues concerning livestock and global food security, veterinary involvement in disaster relief and management, as well as a session celebrating 100 BVA overseas travel grants.
Photograph: Rinderpest virus, copyright held by dr. Rajnish Kaushik
VetSurgeon member Simone Kirby Dip EVDC MRCVS, a veterinary dental specialist in London and Hertfordshire, will be running the BUPA London 10,000 for SPANA: Society for the Protection of Animals Abroad.
The charity provides free veterinary care to working animals (donkeys, mules, horses and camels) in some of the poorest parts of the world. They treat around 400,000 hard-working animals every year, ensuring that they can continue providing an income and livelihood for their impoverished owners. Through an extensive education programme, SPANA speak to animal owners to teach them how to improve husbandry and management. They also have initiatives of visiting schools to encourage positive attitudes to animals in school children.
Simone said: "Please give generously for this worthy cause. It would be wonderful if I can meet my fund-raising target of £1,500 - and every penny counts! Thank You!"
To support Simone, please visit her fund-raising website www.justgiving.com/Simone-Kirby
The RCVS Disciplinary Committee has dismissed a case against a London-based veterinary surgeon, having found charges related to fraudulent registration not proved.
Miss Maria Becerra Parga was charged with fraudulently entering her name on the Register of Veterinary Surgeons, by submitting a registration application in 2005 that contained a forged certificate of good standing from the Distinguished Official Veterinary Association of Lugo, Spain.
The Committee said that, in order to conclude Miss Becerra Parga had acted dishonestly, it needed to be sure that when she submitted the certificate to the RCVS she knew it was not genuine.
Miss Becerra Parga admitted that she did not make any application for the certificate directly to the Lugo Association. She accepted that the certificate she supplied to the College (the number of which was genuine and corresponded to a male veterinary surgeon registered in Spain) was a forgery, and that it contained a reference to her degree, a statement of good conduct, and was dated before she had a need for it; however, she said, this had been given to her by a friend and veterinary colleague and she had understood that she had been given a temporary membership of the Lugo Association for the purpose of registering with the RCVS. She also said that she had left these arrangements to her colleague and assumed that the document she had been given was genuine.
Her colleague, called as a witness by the College, said that Miss Becerra Parga had admitted the fraud to her and she denied that she had given the certificate to Miss Becerra Parga. Her friend said that she gave no more than general guidance because she knew that Miss Becerra Parga would be guided by a UK company that would arrange for her registration with the RCVS and through which she would be employed. She thought it possible that she had told Ms Becerra Parga that she needed a letter of recommendation, but she was not sure.
After careful consideration, the Committee preferred the evidence of Miss Becerra Parga and found her account to be "consistent with her naivety, inexperience and trusting nature" and "was sure that she did not forge the document herself". It found that to the extent that Miss Becerra Parga read the certificate at all when given it, she obviously did not notice its date or significance. The Committee was not able to say who was responsible for forging the certificate.
The Committee also dismissed an argument RCVS Counsel put forward, that Miss Becerra Parga had neither offered nor made payment for the certificate, and that she had forged the certificate to avoid a payment. The Committee said it did not find it credible that a veterinary surgeon, in work with a supportive family, who obviously was easily able to obtain proof of her good character directly from the university if necessary, would have jeopardised her entire career by forging the document, let alone for a small financial advantage.
The Committee directed that the charges be dismissed.